Bacterial cellulose impregnated with andaliman (Zanthoxylum acanthopodium) microencapsulation as diabetic wound dressing.

Diabetic foot ulcer (DFU) is a common complication of diabetes mellitus which can cause infection, amputation and even death. One of many treatments that can be applied to support the DFU healing processes is by using wound dressings. Bacterial cellulose (BC) is a good material to be used as a wound dressing. However, some of the limitations of BC to be applied as wound dressing are does not possess antibacterial properties and support the healing process. Andaliman (Zanthoxylum acanthopodium) is known to have antioxidant, antibacterial and anti-inflammatory abilities that can support BC as a wound dressing. This research focused on the manufacture of BC/Z. acanthopodium microencapsulated wound dressing composites and evaluate their potential as a DFU wound dressing with a variety of gelatin composition in microencapsulation. The results of FTIR and SEM analysis showed that the Z. acanthopodium impregnation process in BC was successful. The variation of gelatine that used in microencapsulation affected the morphological and effectiveness of the wound dressing. However, overall, the wound dressings showed good antibacterial effect on E. coli and S. aureus bacteria and accelerating the wound closure process 8 times faster (BCAMc12) on the 17th day compared to wounds that did not receive any treatment.